AlTorress

IRWD, enters Uptrend as Momentum ascends above 0 level 10/07/20

Long
NASDAQ:IRWD   Ironwood Pharmaceuticals, Inc
This indicator may be signaling that IRWD's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. Tickeron A.I.dvisor backtested 83 similar cases where IRWD's Momentum Indicator exceeded 0, and 71 of them led to a successful outcome. Odds of Success: 86%. Current price $10.25 crossed the resistance line at $9.85 and is trading between $10.25 resistance and $9.85 resistance lines. Throughout the month of 09/04/20 - 10/07/20, the price experienced a +0.87% Uptrend. During the week of 09/30/20 - 10/07/20, the stock enjoyed a +10% Uptrend growth.

Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2020. You may want to consider a long position or call options on IRWD as a result. Tickeron A.I. detected that in 71 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence ( MACD ) for IRWD just turned positive on October 07, 2020. Looking at past instances where IRWD's MACD turned positive, the stock continued to rise, Tickeron A.I. shows that in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

IRWD moved above its 50-day Moving Average on October 07, 2020 date and that indicates a change from a downward trend to an upward trend.

Following a +5.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRWD advanced for three days, Tickeron A.I. detected that in 224 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

IRWD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.